{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=HL8565", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?identifier=HL8565", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=HL8565&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=HL8565&_page=0", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=HL8565", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=HL8565", "items" : [{"_about" : "http://data.parliament.uk/resources/1645390", "AnsweringBody" : [{"_value" : "Home Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1645390/answer", "answerText" : {"_value" : "

The £3 million spend in Turkey in 2022 to 2023 was used to deliver training and equipment and exchange visits in relation to border security and detection of narcotics and illicit cash. An additional spend was utilised to support return and reintegration assistance.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4950", "label" : {"_value" : "Biography information for Lord Murray of Blidworth"} } , "answeringMemberPrinted" : {"_value" : "Lord Murray of Blidworth"} , "dateOfAnswer" : {"_value" : "2023-06-29", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-06-29T11:35:19.53Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "1"} , "answeringDeptShortName" : {"_value" : "Home Office"} , "answeringDeptSortName" : {"_value" : "Home Office"} , "date" : {"_value" : "2023-06-16", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Refugees: Turkey"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what were the reasons for the increase from £425,000 in 2021\u201322 to £3 million in 2023\u201324 in the grant to Turkey for \"return & re-integration assistance\", which was diverted from the Overseas Development Assistance budget to Home Office International Operations; and what guarantees they have received that this grant will not be used for compulsory repatriation or refoulement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2018", "label" : {"_value" : "Biography information for Lord Hylton"} } , "tablingMemberPrinted" : [{"_value" : "Lord Hylton"} ], "uin" : "HL8565"} , {"_about" : "http://data.parliament.uk/resources/1238181", "AnsweringBody" : [{"_value" : "Cabinet Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1238181/answer", "answerText" : {"_value" : "

The Government has made a commitment, in the manifesto and the Queen's Speech, to take forward work to repeal the Fixed Term Parliaments Act. Announcements about the statutory review Committee will be made in due course.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4200", "label" : {"_value" : "Biography information for Lord True"} } , "answeringMemberPrinted" : {"_value" : "Lord True"} , "dateOfAnswer" : {"_value" : "2020-10-12", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-10-12T16:04:43.67Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "53"} , "answeringDeptShortName" : {"_value" : "Cabinet Office"} , "answeringDeptSortName" : {"_value" : "Cabinet Office"} , "date" : {"_value" : "2020-09-28", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Fixed Term Parliaments Act 2011"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what plans they have to announce the arrangements for a committee to carry out a review of the operation of the Fixed Term Parliaments Act 2011, in pursuance of section 7(4)(a) of the Act.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/630", "label" : {"_value" : "Biography information for Lord Wallace of Tankerness"} } , "tablingMemberPrinted" : [{"_value" : "Lord Wallace of Tankerness"} ], "uin" : "HL8565"} , {"_about" : "http://data.parliament.uk/resources/922992", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/922992/answer", "answerText" : {"_value" : "

NHS England\u2019s current model of Clinical Reference Groups (CRG) was established following an extensive public engagement process which was completed during April 2016.<\/p>

Since April 2016, the Cancer National Programme of Care has been supported by five CRGs (Chemotherapy, Radiotherapy, Specialised Cancer Surgery, Specialised Cancer Diagnostics and Children\u2019s and Young People\u2019s Cancer Services). The role of each CRG is to provide the primary source of clinical advice and leadership to NHS England on those services that are nationally commissioned. Each CRG comprises clinicians, patient and public voice representatives, professional association representation, public health experts and a commissioner and will usually meet between two and four times per year.<\/p>

Transparency of decision making is important to NHS England. As a result, both stakeholder testing and public consultation are conducted regularly, in accordance with NHS England\u2019s published Service Development Policy and Methods, in relation to the development of new clinical commissioning policy and service specifications.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"} } , "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"} , "dateOfAnswer" : {"_value" : "2018-06-26", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-06-26T12:17:33.777Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-06-12", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Cancer: Clinical Reference Groups"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what assessment they have made of the transparency of the decision-making process of NHS England in relation to cancer clinical reference groups and the frequency with which such groups meet.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4286", "label" : {"_value" : "Biography information for Lord Mendelsohn"} } , "tablingMemberPrinted" : [{"_value" : "Lord Mendelsohn"} ], "uin" : "HL8565"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 3, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }